How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?
Nephrology Dialysis Transplantation · 2024
DOI: 10.1093/ndt/gfae060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Volker Vallon. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Kidney Tubules, Proximal, Sodium-Glucose Transporter 2 Inhibitors, Glucose. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, U.S. Department of Veterans Affairs, NIH HHS.
Abstract (Originalsprache)
What mechanisms can link the inhibition of sodium-glucose cotransporter 2 (SGLT2) in the early proximal tubule to kidney and heart protection in patients with and without type 2 diabetes? Due to physical and functional coupling of SGLT2 to other sodium and metabolite transporters in the early proximal tubule (including NHE3, URAT1), inhibitors of SGLT2 (SGLT2i) reduce reabsorption not only of glucose, inducing osmotic diuresis, but of other metabolites plus of a larger amount of sodium than expected based on SGLT2 inhibition alone, thereby reducing volume retention, hypertension and hyperuricemia. Metabolic adaptations to SGLT2i include a fasting-like response, with enhanced lipolysis and formation of ketone bodies that serve as additional fuel for kidneys and heart. Making use of the physiology of tubulo-glomerular communication, SGLT2i functionally lower glomerular capillary pressure and filtration rate, thereby reducing physical stress on the glomerular filtration barrier, tubular exposure to albumin and nephrotoxic compounds, and the oxygen demand for reabsorbing the filtered load. Together with reduced gluco-toxicity in the early proximal tubule and better distribution of transport work along the nephron, SGLT2i can preserve tubular integrity and transport function and, thereby, glomerular filtration rate in the long-term. By shifting transport downstream, SGLT2i may simulate systemic hypoxia at the oxygen sensors in the deep cortex/outer medulla, which stimulates erythropoiesis and, together with osmotic diuresis, enhances hematocrit and thereby improves oxygen delivery to all organs. The described SGLT2-dependent effects may be complemented by off-target effects of SGLT2i on the heart itself and on the microbiome formation of cardiovascular-effective uremic toxins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
- Department of Pharmacology, University of California San Diego, La Jolla, CA, USA.
- VA San Diego Healthcare System, San Diego, CA, USA.
ORCID-Profile: Volker Vallon
Förderung
- NIDDK NIH HHS
- U.S. Department of Veterans Affairs
- NIH HHS
- NIA NIH HHS
- University of Alabama at Birmingham
- National Institutes of Health
Zitieren
APA
Vallon, V. (2024). How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae060
Vancouver
Vallon V. How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfae060
BibTeX
@article{Vallon2024,
author = {Vallon, Volker},
title = {How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?},
journal = {Nephrology Dialysis Transplantation},
year = {2024},
doi = {10.1093/ndt/gfae060}
}
EUVIMED